BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18505056)

  • 1. Update on molecular pathology in oral cancer and precancer.
    Campo-Trapero J; Cano-Sánchez J; Palacios-Sánchez B; Sánchez-Gutierrez JJ; González-Moles MA; Bascones-Martínez A
    Anticancer Res; 2008; 28(2B):1197-205. PubMed ID: 18505056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Soft tissue pathologies of the oral cavity].
    Margotta V; Capogreco M
    Minerva Stomatol; 2003; 52(1-2):47-51. PubMed ID: 12686915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hamster model of sequential oral oncogenesis.
    Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
    Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation in oral cancer and pre-cancerous lesions (Review).
    Díez-Pérez R; Campo-Trapero J; Cano-Sánchez J; López-Durán M; Gonzalez-Moles MA; Bascones-Ilundain J; Bascones-Martinez A
    Oncol Rep; 2011 May; 25(5):1203-9. PubMed ID: 21380489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer.
    Acha A; Ruesga MT; Rodríguez MJ; Martínez de Pancorbo MA; Aguirre JM
    Med Oral Patol Oral Cir Bucal; 2005; 10(2):95-102. PubMed ID: 15735540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular senescence in oral cancer and precancer and treatment implications: a review.
    Campo-Trapero J; Cano-Sánchez J; Palacios-Sánchez B; Llamas-Martínez S; Lo Muzio L; Bascones-Martínez A
    Acta Oncol; 2008; 47(8):1464-74. PubMed ID: 18607883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic progression model of oral cancer: current evidence and clinical implications.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history and pathology of oral cancer and precancer.
    Speight PM; Morgan PR
    Community Dent Health; 1993 Jun; 10 Suppl 1():31-41. PubMed ID: 8402306
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral cancer prevention and the evolution of molecular-targeted drug development.
    Lippman SM; Sudbø J; Hong WK
    J Clin Oncol; 2005 Jan; 23(2):346-56. PubMed ID: 15637397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary concepts in the diagnosis of oral cancer and precancer.
    Natarajan E; Eisenberg E
    Dent Clin North Am; 2011 Jan; 55(1):63-88. PubMed ID: 21094719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of oral squamous carcinoma.
    Williams HK
    Mol Pathol; 2000 Aug; 53(4):165-72. PubMed ID: 11040937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral squamous cell carcinoma and biological markers: an update on the molecules mainly involved in oral carcinogenesis.
    Lo Muzio L; Santarelli A; Panzarella V; Campisi G; Carella M; Ciavarella D; Di Cosola M; Giannone N; Bascones A
    Minerva Stomatol; 2007 Jun; 56(6):341-7. PubMed ID: 17625491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immuno-pathological and immunological features of oral precancers.
    Pillai MR; Nair MK; Kannan S; Chandran GJ; Balaram P
    Singapore Dent J; 1993 Jun; 18(1):28-38. PubMed ID: 9582692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of premalignant oral lesions.
    Mithani SK; Mydlarz WK; Grumbine FL; Smith IM; Califano JA
    Oral Dis; 2007 Mar; 13(2):126-33. PubMed ID: 17305612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
    Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
    Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New molecular targets in pancreatic cancer].
    Torrisani J; Bournet B; Cordelier P; Buscail L
    Bull Cancer; 2008 May; 95(5):503-12. PubMed ID: 18541514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of genetic assays to identify oral pre-cancerous fields.
    Bremmer JF; Braakhuis BJ; Brink A; Broeckaert MA; Beliën JA; Meijer GA; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
    J Oral Pathol Med; 2008 Nov; 37(10):599-606. PubMed ID: 18705641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The examination of DNA repair capacity in the patients with oral precancerous lesion].
    Lin M; Yue Y; Li B; Zhou M; Xie J; Zhang G; He Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Aug; 19(4):213-5. PubMed ID: 12539722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.